Partners that Unleash ADC Potential
We combine AJICAP™ conjugation technology with a qualified network of global CDMO partners to support your ADC program from early evaluation through clinical manufacturing. We provide process development and technology transfer support, while GMP manufacturing is performed by qualified partner CDMOs. This model gives you access to established manufacturing capabilities while maintaining flexibility in development and supply.
What Sets Our Network Apart
Seamless Technology Transfer
AJICAP™ supports efficient technology transfer from process development to GMP manufacturing through well-established transfer packages and technical collaboration with qualified CDMO partners. Process knowledge, analytical methods, and manufacturing considerations are shared to facilitate a smooth transition while reducing development timelines and manufacturing risk.
Global Regulatory Alignment
AJICAP™ works with experienced CDMO partners that support programs intended for global development. Partner selection considers manufacturing experience, quality systems, and regulatory expectations relevant to the target market, including FDA, EMA, and PMDA requirements where applicable.
Integrated Quality Systems
AJICAP™ maintains technical oversight throughout development and technology transfer activities. Quality expectations, analytical requirements, and process information are communicated to manufacturing partners to support consistent execution and product quality across development stages.
Our Qualified CDMO Partnerships
Each CDMO brings distinct strengths to the network.
NJ Bio
Integrated drug discovery and development partner providing AJICAP™-enabled ADC candidate development and early-stage support.
Piramal Pharma Solutions
Global CDMO with 20+ years of ADC experience, providing development and GMP manufacturing for AJICAP™-based products through commercial scale.
Ready to Move Forward?
From first conjugate through clinical supply, explore the pathway that fits your program.
Frequently Asked Questions
Does Ajinomoto Bio-Pharma Services manufacture ADCs in-house?
Ajinomoto Bio-Pharma Services provides AJICAP™ conjugation technology and linker technology, as well as process development, analytical support, and technology transfer. GMP manufacturing may be performed by qualified AJICAP™ partner CDMOs or by customer-selected manufacturing partners. This flexible model allows customers to choose the manufacturing strategy that best fits their development needs.
Can I use my own CDMO with AJICAP™?
Yes. Customers may work with their preferred CDMO partner. AJICAP™ supports process development and technology transfer and can work with customer-selected manufacturing partners. Ajinomoto Bio-Pharma Services’ partner CDMOs are also available for customers seeking established ADC manufacturing capabilities and prior AJICAP™ technology transfer experience.